Evidence map›Paper›PMID 31215463›Full record

ArticleSystematic reviews2019

A question of trust: can we build an evidence base to gain trust in systematic review automation technologies?

Annette M O'Connor, Guy Tsafnat, James Thomas, Paul Glasziou, Stephen B Gilbert, Brian Hutton

Abstract read
In one paragraph

Article in Systematic reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Automated tools in systematic reviews: Current trends.Indian journal of anaesthesia · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. New opportunities and challenges for conservation evidence synthesis from advances in natural language processing.Conservation biology : the journal of the Society for Conservation Biology · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Annette M O'ConnorCollege of Veterinary Medicine, Iowa State University, Ames, IA, 50011, USA. oconnor@iastate.edu.ORCID 0000-0003-0604-7822
Guy TsafnatAustralian Institute of Health Innovation, Macquarie University, Sydney, Australia.
James ThomasUniversity College London, London, WC1E 6BT, UK.
Paul GlasziouBond University, Robina, QLD, 4226, Australia.
Stephen B GilbertCollege of Engineering, Iowa State University, Ames, IA, 50011, USA.
Brian HuttonKnowledge Synthesis Unit, Ottawa Hospital Research Institute, Ottawa, ON, K1H 8L6, Canada.

Funding

Medical Research Council MR/J005037/1
6 · The paper itself

Abstract

backgroundAlthough many aspects of systematic reviews use computational tools, systematic reviewers have been reluctant to adopt machine learning tools. DISCUSSION: We discuss that the potential reason for the slow adoption of machine learning tools into systematic reviews is multifactorial. We focus on the current absence of trust in automation and set-up challenges as major barriers to adoption. It is important that reviews produced using automation tools are considered non-inferior or superior to current practice. However, this standard will likely not be sufficient to lead to widespread adoption. As with many technologies, it is important that reviewers see "others" in the review community using automation tools. Adoption will also be slow if the automation tools are not compatible with workflows and tasks currently used to produce reviews. Many automation tools being developed for systematic reviews mimic classification problems. Therefore, the evidence that these automation tools are non-inferior or superior can be presented using methods similar to diagnostic test evaluations, i.e., precision and recall compared to a human reviewer. However, the assessment of automation tools does present unique challenges for investigators and systematic reviewers, including the need to clarify which metrics are of interest to the systematic review community and the unique documentation challenges for reproducible software experiments.

conclusionWe discuss adoption barriers with the goal of providing tool developers with guidance as to how to design and report such evaluations and for end users to assess their validity. Further, we discuss approaches to formatting and announcing publicly available datasets suitable for assessment of automation technologies and tools. Making these resources available will increase trust that tools are non-inferior or superior to current practice. Finally, we identify that, even with evidence that automation tools are non-inferior or superior to current practice, substantial set-up challenges remain for main stream integration of automation into the systematic review process.

Indexed as

Machine LearningSystematic Reviews as TopicEvidence-Based PracticeHumansReproducibility of ResultsTrustArtificial intelligenceAutomationData extractionMachine learningScreening

Identifiers

PMID31215463
PMCPMC6582554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.